| Price | 6.75p on 07-05-2026 at 18:25:09 |
|---|---|
| Change | 0.05p 0.75% |
| Buy | 6.80p |
| Sell | 6.70p |
| Last Trade: | Unknown 500,000.00 at 6.75p |
| Day's Volume: | 5,425,867 |
| Last Close: | 6.75p |
| Open: | 6.75p |
| ISIN: | GB00BYV81293 |
| Day's Range | 6.65p - 6.75p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £72.12m |
| VWAP: | 6.70763p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 500,000 | 6.75p | OTC Trade |
17:06:25 - 07-May-26 |
| Sell* | 350,000 | 6.70p | Ordinary |
16:37:50 - 07-May-26 |
| Buy* | 51,052 | 6.80p | Suspected BUY Trade |
16:32:47 - 07-May-26 |
| Sell* | 4,152 | 6.725p | Ordinary |
16:28:45 - 07-May-26 |
| Unknown* | 50,000 | 6.75p | Ordinary |
16:25:55 - 07-May-26 |
| Buy* | 147,433 | 6.78p | Ordinary |
16:24:24 - 07-May-26 |
| Buy* | 8,575 | 6.80p | Ordinary |
16:23:23 - 07-May-26 |
| Buy* | 135 | 6.80p | Ordinary |
16:23:23 - 07-May-26 |
| Buy* | 135 | 6.80p | SI Trade |
16:23:23 - 07-May-26 |
| Buy* | 15 | 6.80p | SI Trade |
16:23:23 - 07-May-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th May 2026 7:00 am | RNS | Grant of Share Options |
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
